Hepatocyte growth factor predicts survival and relates to inflammation and intima media thickness in end-stage renal disease

Lorenzo S. Malatino, Francesca Mallamaci, Francesco A. Benedetto, Ignazio Bellanuova, Alessandro Cataliotti, Giovanni Tripepi, Carmine Zoccali

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Hepatocyte growth factor (HGF) is a pleiotropic cytokine involved in tissue protection and repair in the endothelium and various organ systems. The serum concentration of this protein is markedly increased in patients with chronic renal diseases, but the clinical and pathophysiological correlates of this substance in renal failure are scarcely understood. Serum HGF, lipid, albumin, hemoglobin, C-reactive protein (CRP), and immunoglobulin G (IgG) were measured in fasting conditions in a cohort of 244 dialysis patients. In addition, the relationship between HGF and severity of carotid atherosclerosis was studied in a subgroup of 105 patients. The entire cohort was followed up for a median of 31 months (interquartile range, 21 to 34 months). Serum HGF level was directly related to duration of dialysis treatment, CRP level, age, IgG level, and hemoglobin level and inversely related to systolic and diastolic arterial blood pressure. In a multiple regression model, only duration of dialysis treatment (r = 0.38), age (r = 0.26), hemoglobin level (r = 0.17), IgG level (r = 0.15), and CRP level (r = 0.14) were independent correlates of serum HGF level (R = 0.54; P < 0.0001), suggesting that increased levels of serum HGF may be the expression of a chronic inflammatory process. HGF levels were greater in hemodialysis than continuous ambulatory peritoneal dialysis patients, independent of the type of dialysis membrane, and slightly increased in patients seropositive for hepatitis C virus. In the subgroup of patients who underwent echo color Doppler studies, serum HGF level was an independent correlate of intima media thickness (IMT; partial r = 0.23; P = 0.02). In the entire cohort, increased HGF levels predicted shorter survival in a multivariate Cox regression model. These results support the hypothesis that in patients with chronic renal failure, increased serum HGF level is linked to an inflammatory state. The relationships between HGF level and survival and IMT suggest that this cytokine might be a marker of a process that has a major impact in the high mortality and morbidity of the dialysis population. (C) 2000 by the National Kidney Foundation, Inc.

Original languageEnglish (US)
Pages (from-to)945-952
Number of pages8
JournalAmerican Journal of Kidney Diseases
Volume36
Issue number5
StatePublished - 2000
Externally publishedYes

Fingerprint

Hepatocyte Growth Factor
Chronic Kidney Failure
Inflammation
Survival
Dialysis
Serum
C-Reactive Protein
Immunoglobulin G
Hemoglobins
Hemoglobin C
Cytokines
Carotid Artery Diseases
Continuous Ambulatory Peritoneal Dialysis
Chronic Renal Insufficiency
Proportional Hazards Models
Hepacivirus
Endothelium
Renal Insufficiency
Renal Dialysis
Blood Proteins

Keywords

  • Atherosclerosis
  • Chronic renal failure
  • Cytokines
  • Dialysis
  • Hepatocyte growth factor (HGF)

ASJC Scopus subject areas

  • Nephrology

Cite this

Malatino, L. S., Mallamaci, F., Benedetto, F. A., Bellanuova, I., Cataliotti, A., Tripepi, G., & Zoccali, C. (2000). Hepatocyte growth factor predicts survival and relates to inflammation and intima media thickness in end-stage renal disease. American Journal of Kidney Diseases, 36(5), 945-952.

Hepatocyte growth factor predicts survival and relates to inflammation and intima media thickness in end-stage renal disease. / Malatino, Lorenzo S.; Mallamaci, Francesca; Benedetto, Francesco A.; Bellanuova, Ignazio; Cataliotti, Alessandro; Tripepi, Giovanni; Zoccali, Carmine.

In: American Journal of Kidney Diseases, Vol. 36, No. 5, 2000, p. 945-952.

Research output: Contribution to journalArticle

Malatino, LS, Mallamaci, F, Benedetto, FA, Bellanuova, I, Cataliotti, A, Tripepi, G & Zoccali, C 2000, 'Hepatocyte growth factor predicts survival and relates to inflammation and intima media thickness in end-stage renal disease', American Journal of Kidney Diseases, vol. 36, no. 5, pp. 945-952.
Malatino LS, Mallamaci F, Benedetto FA, Bellanuova I, Cataliotti A, Tripepi G et al. Hepatocyte growth factor predicts survival and relates to inflammation and intima media thickness in end-stage renal disease. American Journal of Kidney Diseases. 2000;36(5):945-952.
Malatino, Lorenzo S. ; Mallamaci, Francesca ; Benedetto, Francesco A. ; Bellanuova, Ignazio ; Cataliotti, Alessandro ; Tripepi, Giovanni ; Zoccali, Carmine. / Hepatocyte growth factor predicts survival and relates to inflammation and intima media thickness in end-stage renal disease. In: American Journal of Kidney Diseases. 2000 ; Vol. 36, No. 5. pp. 945-952.
@article{3ea74ba7a839435a83708fe7505d88ae,
title = "Hepatocyte growth factor predicts survival and relates to inflammation and intima media thickness in end-stage renal disease",
abstract = "Hepatocyte growth factor (HGF) is a pleiotropic cytokine involved in tissue protection and repair in the endothelium and various organ systems. The serum concentration of this protein is markedly increased in patients with chronic renal diseases, but the clinical and pathophysiological correlates of this substance in renal failure are scarcely understood. Serum HGF, lipid, albumin, hemoglobin, C-reactive protein (CRP), and immunoglobulin G (IgG) were measured in fasting conditions in a cohort of 244 dialysis patients. In addition, the relationship between HGF and severity of carotid atherosclerosis was studied in a subgroup of 105 patients. The entire cohort was followed up for a median of 31 months (interquartile range, 21 to 34 months). Serum HGF level was directly related to duration of dialysis treatment, CRP level, age, IgG level, and hemoglobin level and inversely related to systolic and diastolic arterial blood pressure. In a multiple regression model, only duration of dialysis treatment (r = 0.38), age (r = 0.26), hemoglobin level (r = 0.17), IgG level (r = 0.15), and CRP level (r = 0.14) were independent correlates of serum HGF level (R = 0.54; P < 0.0001), suggesting that increased levels of serum HGF may be the expression of a chronic inflammatory process. HGF levels were greater in hemodialysis than continuous ambulatory peritoneal dialysis patients, independent of the type of dialysis membrane, and slightly increased in patients seropositive for hepatitis C virus. In the subgroup of patients who underwent echo color Doppler studies, serum HGF level was an independent correlate of intima media thickness (IMT; partial r = 0.23; P = 0.02). In the entire cohort, increased HGF levels predicted shorter survival in a multivariate Cox regression model. These results support the hypothesis that in patients with chronic renal failure, increased serum HGF level is linked to an inflammatory state. The relationships between HGF level and survival and IMT suggest that this cytokine might be a marker of a process that has a major impact in the high mortality and morbidity of the dialysis population. (C) 2000 by the National Kidney Foundation, Inc.",
keywords = "Atherosclerosis, Chronic renal failure, Cytokines, Dialysis, Hepatocyte growth factor (HGF)",
author = "Malatino, {Lorenzo S.} and Francesca Mallamaci and Benedetto, {Francesco A.} and Ignazio Bellanuova and Alessandro Cataliotti and Giovanni Tripepi and Carmine Zoccali",
year = "2000",
language = "English (US)",
volume = "36",
pages = "945--952",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Hepatocyte growth factor predicts survival and relates to inflammation and intima media thickness in end-stage renal disease

AU - Malatino, Lorenzo S.

AU - Mallamaci, Francesca

AU - Benedetto, Francesco A.

AU - Bellanuova, Ignazio

AU - Cataliotti, Alessandro

AU - Tripepi, Giovanni

AU - Zoccali, Carmine

PY - 2000

Y1 - 2000

N2 - Hepatocyte growth factor (HGF) is a pleiotropic cytokine involved in tissue protection and repair in the endothelium and various organ systems. The serum concentration of this protein is markedly increased in patients with chronic renal diseases, but the clinical and pathophysiological correlates of this substance in renal failure are scarcely understood. Serum HGF, lipid, albumin, hemoglobin, C-reactive protein (CRP), and immunoglobulin G (IgG) were measured in fasting conditions in a cohort of 244 dialysis patients. In addition, the relationship between HGF and severity of carotid atherosclerosis was studied in a subgroup of 105 patients. The entire cohort was followed up for a median of 31 months (interquartile range, 21 to 34 months). Serum HGF level was directly related to duration of dialysis treatment, CRP level, age, IgG level, and hemoglobin level and inversely related to systolic and diastolic arterial blood pressure. In a multiple regression model, only duration of dialysis treatment (r = 0.38), age (r = 0.26), hemoglobin level (r = 0.17), IgG level (r = 0.15), and CRP level (r = 0.14) were independent correlates of serum HGF level (R = 0.54; P < 0.0001), suggesting that increased levels of serum HGF may be the expression of a chronic inflammatory process. HGF levels were greater in hemodialysis than continuous ambulatory peritoneal dialysis patients, independent of the type of dialysis membrane, and slightly increased in patients seropositive for hepatitis C virus. In the subgroup of patients who underwent echo color Doppler studies, serum HGF level was an independent correlate of intima media thickness (IMT; partial r = 0.23; P = 0.02). In the entire cohort, increased HGF levels predicted shorter survival in a multivariate Cox regression model. These results support the hypothesis that in patients with chronic renal failure, increased serum HGF level is linked to an inflammatory state. The relationships between HGF level and survival and IMT suggest that this cytokine might be a marker of a process that has a major impact in the high mortality and morbidity of the dialysis population. (C) 2000 by the National Kidney Foundation, Inc.

AB - Hepatocyte growth factor (HGF) is a pleiotropic cytokine involved in tissue protection and repair in the endothelium and various organ systems. The serum concentration of this protein is markedly increased in patients with chronic renal diseases, but the clinical and pathophysiological correlates of this substance in renal failure are scarcely understood. Serum HGF, lipid, albumin, hemoglobin, C-reactive protein (CRP), and immunoglobulin G (IgG) were measured in fasting conditions in a cohort of 244 dialysis patients. In addition, the relationship between HGF and severity of carotid atherosclerosis was studied in a subgroup of 105 patients. The entire cohort was followed up for a median of 31 months (interquartile range, 21 to 34 months). Serum HGF level was directly related to duration of dialysis treatment, CRP level, age, IgG level, and hemoglobin level and inversely related to systolic and diastolic arterial blood pressure. In a multiple regression model, only duration of dialysis treatment (r = 0.38), age (r = 0.26), hemoglobin level (r = 0.17), IgG level (r = 0.15), and CRP level (r = 0.14) were independent correlates of serum HGF level (R = 0.54; P < 0.0001), suggesting that increased levels of serum HGF may be the expression of a chronic inflammatory process. HGF levels were greater in hemodialysis than continuous ambulatory peritoneal dialysis patients, independent of the type of dialysis membrane, and slightly increased in patients seropositive for hepatitis C virus. In the subgroup of patients who underwent echo color Doppler studies, serum HGF level was an independent correlate of intima media thickness (IMT; partial r = 0.23; P = 0.02). In the entire cohort, increased HGF levels predicted shorter survival in a multivariate Cox regression model. These results support the hypothesis that in patients with chronic renal failure, increased serum HGF level is linked to an inflammatory state. The relationships between HGF level and survival and IMT suggest that this cytokine might be a marker of a process that has a major impact in the high mortality and morbidity of the dialysis population. (C) 2000 by the National Kidney Foundation, Inc.

KW - Atherosclerosis

KW - Chronic renal failure

KW - Cytokines

KW - Dialysis

KW - Hepatocyte growth factor (HGF)

UR - http://www.scopus.com/inward/record.url?scp=0033753622&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033753622&partnerID=8YFLogxK

M3 - Article

C2 - 11054350

AN - SCOPUS:0033753622

VL - 36

SP - 945

EP - 952

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

SN - 0272-6386

IS - 5

ER -